Market performance YTD (2019): Index Dec 31, 2018 close Feb 1, 2019 close Feb 8, 2019 close YTD gain/loss YTD percentage change $DJIA 23,327.46 25,063.14 25,106.33 +1,778.87 7.626% $SPX 2,506.85 2,706.53 2,707.88 +201.03 8.019% $NDX 6,329.96 6,875.52 6,913.13 +583.17 9.213% $RUT 1,348.56 1,502.05 1,506.39 +157.83 11.704% Markets are up between 7.6% - 11.7%. How have you done so far in 2019? Monday’s trades: $VZ - dividend yield is 4.5%. Sure, yahoo is junk, tumblr is all but worthless but Jan 29 earnings should affirm the single-digit EPS growth for the year. $VZ, Verizon Communications Inc. / H1 $AMD – Radeon 7 release came and went. Stock may trade on the merits of Ryzen and EPYC. $AMD, Advanced Micro Devices, Inc. / H1 $USO – oil prices dipped unnecessarily. This ETF will give investors exposure to the energy sector. $USO, United States Oil Fund / H1 $TGT – reports the following week and already corrected. $TGT, Target Corporation / H1 Walmart $WMT is deep value too. $CVS – is stuck in a range, giving up all of the run-up that followed from the Aetna acquisition. CVS reports Feb 20 BMO. $CVS, CVS Health Corporation / H1 $MCD - can do no wrong. Demand keeps growing and marketing initiatives are all bringing in traffic. $MCD, McDonald's Corporation / H1 $UNH corrected 2.54% lower on the week. The government attack on drug pricing will lead nowhere and UNH, CVS will not face any revenue headwinds. For members and subscribers only, $XBIT - XBiotech, which is developing an atopic dermatitis drug, similar to $REGN - Regeneron's Dupixent, has done well for us: $XBIT, XBiotech Inc. / H1 Did you sell XBIT stock as instructed at $10.70? Would you buy $CRSP, $NKTR next?